Biotechnology Assets SA banner

Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.19 EUR 2.43% Market Closed
Market Cap: €13.8m

Balance Sheet

Balance Sheet Decomposition
Biotechnology Assets SA

Balance Sheet
Biotechnology Assets SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
0
1
0
1
1
0
0
1
4
5
1
2
1
0
0
Cash
0
0
0
0
0
0
0
0
4
5
1
2
1
0
0
Cash Equivalents
0
1
0
0
1
0
0
1
0
0
0
0
0
0
0
Short-Term Investments
1
0
0
0
1
1
1
1
1
2
0
0
0
0
0
Total Receivables
1
1
1
0
2
2
1
2
9
16
3
3
2
3
3
Accounts Receivables
1
1
1
0
2
2
1
1
7
14
3
3
2
3
3
Other Receivables
0
0
1
0
0
0
0
0
2
2
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
7
8
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Assets
1
2
2
1
4
3
2
3
20
30
3
4
3
4
4
PP&E Net
2
2
2
3
3
3
3
3
37
41
3
3
3
2
2
PP&E Gross
0
2
2
3
0
0
0
0
0
0
3
3
3
2
2
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
0
1
2
2
3
Intangible Assets
1
2
2
2
5
5
5
5
8
7
6
6
6
5
4
Goodwill
0
0
0
0
0
0
3
2
7
7
4
3
3
2
1
Long-Term Investments
0
0
0
1
0
0
0
0
2
2
0
0
0
1
0
Other Long-Term Assets
1
1
2
2
2
3
3
4
5
5
3
3
3
3
3
Other Assets
0
0
0
0
0
0
3
2
7
7
4
3
3
2
1
Total Assets
5
N/A
7
+45%
8
+4%
9
+22%
15
+59%
15
+1%
16
+8%
18
+10%
79
+352%
93
+17%
20
-78%
20
-2%
18
-7%
17
-10%
15
-11%
Liabilities
Accounts Payable
0
0
0
0
0
0
0
0
5
3
0
0
0
0
0
Accrued Liabilities
0
0
0
0
0
0
0
0
1
1
0
0
0
1
1
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
0
0
1
1
1
1
0
7
8
1
0
1
1
2
Other Current Liabilities
0
0
0
1
1
1
1
2
10
17
8
3
2
2
2
Total Current Liabilities
0
1
1
1
2
2
2
2
23
29
10
4
4
4
5
Long-Term Debt
3
4
4
4
5
5
5
1
13
11
2
3
3
3
1
Deferred Income Tax
0
0
0
0
0
0
0
0
1
1
1
1
1
1
0
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
6
25
44
4
8
7
3
2
Total Liabilities
3
N/A
5
+65%
5
+1%
5
+5%
7
+40%
7
+3%
8
+10%
9
+19%
62
+552%
85
+38%
16
-81%
15
-5%
14
-6%
10
-31%
8
-18%
Equity
Common Stock
0
0
0
0
0
0
0
0
2
2
2
2
3
3
3
Retained Earnings
1
1
1
1
3
2
1
1
72
82
91
94
96
94
98
Additional Paid In Capital
0
0
1
1
4
4
6
6
86
86
92
95
96
97
100
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
1
1
1
2
1
1
1
1
2
2
1
1
1
1
1
Total Equity
2
N/A
3
+19%
3
+10%
4
+48%
8
+81%
8
-1%
8
+6%
8
+1%
18
+119%
8
-57%
4
-48%
4
+13%
4
-10%
7
+66%
7
-1%
Total Liabilities & Equity
5
N/A
7
+45%
8
+4%
9
+22%
15
+59%
15
+1%
16
+8%
18
+10%
79
+352%
93
+17%
20
-78%
20
-2%
18
-7%
17
-10%
15
-11%
Shares Outstanding
Common Shares Outstanding
4
4
4
4
5
5
5
5
39
39
39
46
54
58
58